高清不卡日本v二区在线,天天综合网天天综合,激情丁香五月天婷婷水蜜桃视频,91精品免费久久久久久久久,手机看片久久久久久久久,日日夜夜嫩草,日本不卡 在线视频,欧美亚洲日韩,高潮歹无毛免费观看视频,天天综合网7799日日夜夜永,欧美日本国产日韩激情视频 ,久久久无码精品亚洲日韩蜜桃,日夜夜天天人人综合网,91蜜桃长长久久,国产精品精品一区在线发布,一级a毛片免费观看久久精品

Can You Provide an Overview of the General Timeline for FDA Registration and Certification?
Category：行業(yè)資訊 Date：2024-08-21 17:26:24 Author: Source:
These timelines are subject to change based on factors such as the completeness of the application, the need for additional information, and the FDA's workload. It is crucial for applicants to thoroughly prepare their submissions and promptly respond to any FDA requests to avoid delays.

The timeline for FDA registration and certification varies based on the type of product and the specific regulatory pathway. Here is a general overview:1(3).jpg

  1. Medical Devices:

    • 510(k) Notification: The FDA typically reviews 510(k) submissions within 90 days. However, if additional information is requested, it can extend the review period. Companies should prepare for potential back-and-forth communication, which could add time.
    • Premarket Approval (PMA): The PMA process is more rigorous and generally takes 180 to 360 days. This timeline can vary based on the complexity of the device and the completeness of the application. The process includes detailed reviews of clinical and non-clinical data.
    • De Novo Classification: Usually takes about 120 days. This process is for new types of devices that are not substantially equivalent to existing devices and require a new classification.

  2. Drugs:

    • New Drug Application (NDA): Standard review takes about 10 months, while priority review can shorten this to 6 months. The review process involves evaluating the safety and efficacy of the drug based on clinical trials and other data.
    • Abbreviated New Drug Application (ANDA): Generally takes around 10 months. This process is for generic drugs and involves demonstrating that the generic is equivalent to an existing approved drug.

  3. Biologics:

    • Biologics License Application (BLA): Typically reviewed within 10 months. For products that meet criteria for priority review, the timeline can be reduced to 6 months. This process evaluates the safety and effectiveness of biological products, including vaccines and blood products.

  4. Food Products:

    • Generally Recognized as Safe (GRAS) Notification: The review process may take several months to a year. GRAS notifications involve evaluating the safety of new food ingredients or substances.

These timelines are subject to change based on factors such as the completeness of the application, the need for additional information, and the FDA's workload. It is crucial for applicants to thoroughly prepare their submissions and promptly respond to any FDA requests to avoid delays.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn